Application

14729630 · Urinary Triaosylceramide (GB3) as a Marker of Cardiac Disease

Filed 2015-06-03 · Granted · Patent 9750732 (2017-09-05) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Michael J Schmitt Typical · CPC A61K 31/445 · Baylor Research Institute · Servilla Whitney LLC/ACS

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

16.3 mo

to disposition 27.1 mo

Statutes raised

101 103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.